Clinical Gastroenterology and Hepatology
Volume 6, Issue 1 , Pages 82-88 , January 2008

Trypsinogen Copy Number Mutations in Patients With Idiopathic Chronic Pancreatitis

  • Emmanuelle Masson

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), U613, Brest, France
    • Faculté de Médecine de Brest et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France
    • Drs Masson and Le Maréchal contributed equally to this work.
    • ,
  • Cédric Le Maréchal

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), U613, Brest, France
    • Faculté de Médecine de Brest et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France
    • Laboratoire de Génétique Moléculaire et d’Histocompatibilité, Centre Hospitalier Universitaire de Brest, Hôpital Morvan, Brest, France
    • Etablissement Français du Sang – Bretagne, Brest, France
    • Drs Masson and Le Maréchal contributed equally to this work.
    • ,
  • Giriraj R. Chandak

      Affiliations

    • Genome Research Group, Centre for Cellular and Molecular Biology, Hyderabad, India
    • ,
  • Jérôme Lamoril

      Affiliations

    • Centre Français des Porphyries, Université Paris VII, Hôpital Louis Mourier, Colombes, France
    • ,
  • Stephane Bezieau

      Affiliations

    • Laboratoire d’Etude du Polymorphisme de l’ADN, EA3823, Faculté de Médecine, Nantes, France
    • ,
  • Swapna Mahurkar

      Affiliations

    • Genome Research Group, Centre for Cellular and Molecular Biology, Hyderabad, India
    • ,
  • Seema Bhaskar

      Affiliations

    • Genome Research Group, Centre for Cellular and Molecular Biology, Hyderabad, India
    • ,
  • D. Nageshwar Reddy

      Affiliations

    • Asian Institute of Gastroenterology, Punjagutta, Hyderabad, India
    • ,
  • Jian-Min Chen

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), U613, Brest, France
    • Etablissement Français du Sang – Bretagne, Brest, France
    • Corresponding Author InformationAddress requests for reprints to: Jian-Min Chen, MD, PhD, INSERM U613, Etablissement Français du Sang – Bretagne, 46 rue Félix Le Dantec, 29220 Brest, France. fax: +33-2-98430555.
    • ,
  • Claude Férec

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), U613, Brest, France
    • Faculté de Médecine de Brest et des Sciences de la Santé, Université de Bretagne Occidentale, Brest, France
    • Laboratoire de Génétique Moléculaire et d’Histocompatibilité, Centre Hospitalier Universitaire de Brest, Hôpital Morvan, Brest, France
    • Etablissement Français du Sang – Bretagne, Brest, France

References 

  1. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707
  2. Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology. 1952;21:54–63
  3. Chiara H. Ueber Selbstverdauung des menschlichen Pankreas. Ztschr Heilkunde. 1896;17:70–96
  4. Le Bodic L, Bignon JD, Raguénès O, et al. The hereditary pancreatitis gene maps to long arm of chromosome 7. Hum Mol Genet. 1996;5:549–554
  5. Whitcomb DC, Preston RA, Aston CE, et al. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology. 1996;110:1975–1980
  6. Pandya A, Blanton SH, Landa B, et al. Linkage studies in a large kindred with hereditary pancreatitis confirms mapping of the gene to a 16-cM region on 7q. Genomics. 1996;38:227–230
  7. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141–145
  8. Chen JM, Kukor Z, Le Maréchal C, et al. Evolution of trypsinogen activation peptides. Mol Biol Evol. 2003;20:1767–1777
  9. Teich N, Ockenga J, Hoffmeister A, et al. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology. 2000;119:461–465
  10. Sahin-Tóth M. Human cationic trypsinogen: role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem. 2000;275:22750–22755
  11. Sahin-Tóth M, Tóth M. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun. 2000;278:286–289
  12. Archer H, Jura N, Keller J, et al. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology. 2006;131:1844–1855
  13. Chen JM, Férec C. Human trypsins. In:  Barrett AJ,  Rawlings ND,  Woessner JF editor. Handbook of proteolytic enzymes. 2nd ed.. London: Elsevier; 2004;p. 1489–1493
  14. Chen JM, Le Maréchal C, Lucas D, et al. “Loss of function” mutations in the cationic trypsinogen gene (PRSS1) may act as a protective factor against pancreatitis. Mol Genet Metab. 2003;79:67–70
  15. Witt H, Sahin-Tóth M, Landt O, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38:668–673
  16. Chen JM, Mercier B, Audrézet MP, et al. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet. 2000;37:67–69
  17. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213–216
  18. Pfutzer RH, Barmada MM, Brunskill AP, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000;119:615–623
  19. Gaia E, Salacone P, Gallo M, et al. Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci. 2002;47:2416–2421
  20. Chandak GR, Idris MM, Reddy DN, et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet. 2002;39:347–351
  21. Bhatia E, Choudhuri G, Sikora SS, et al. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology. 2002;123:1020–1025
  22. Schneider A, Suman A, Rossi L, et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology. 2002;123:1026–1030
  23. Le Maréchal C, Chen JM, Le Gall C, et al. Two novel severe mutations in the pancreatic secretory trypsin inhibitor gene (SPINK1) cause familial and/or hereditary pancreatitis. Hum Mutat. 2004;23:205
  24. Kiraly O, Boulling A, Witt H, et al. Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat. 2007;28:469–476
  25. Boulling A, Le Maréchal C, Trouvé P, et al. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet. 2007;15:936–942
  26. Kiraly O, Wartmann T, Sahin-Toth M. Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut. 2007;56:1433–1438
  27. Masson E, Le Maréchal C, Chen JM, et al. Detection of a large genomic deletion in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet. 2006;14:1204–1208
  28. Masson E, Le Maréchal C, Levy P, et al. Co-inheritance of a novel deletion of the entire SPINK1 gene with a CFTR missense mutation (L997F) in a family with chronic pancreatitis. Mol Genet Metab. 2007;92:168–175
  29. Le Maréchal C, Masson E, Chen JM, et al. Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet. 2006;38:1372–1374
  30. Scherer SW, Lee C, Birney E, et al. Challenges and standards in integrating surveys of structural variation. Nat Genet. 2007;39:S7–S15
  31. Tuzun E, Sharp AJ, Bailey JA, et al. Fine-scale structural variation of the human genome. Nat Genet. 2005;37:727–732
  32. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454
  33. Wong KK, deLeeuw RJ, Dosanjh NS, et al. A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet. 2007;80:91–104
  34. Le Maréchal C, Bretagne JF, Raguénès O, et al. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1). Mol Genet Metab. 2001;74:342–344
  35. Le Maréchal C, Audrézet MP, Quéré I, et al. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum Genet. 2001;108:290–298
  36. McCarroll SA, Hadnott TN, Perry GH, et al. Common deletion polymorphisms in the human genome. Nat Genet. 2006;38:86–92
  37. Chen JM, Mercier B, Audrézet MP, et al. Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology. 2001;120:1061–1064
  38. Witt H, Luck W, Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology. 1999;117:7–10
  39. Chen JM, Raguenes O, Ferec C, et al. The A16V signal peptide cleavage site mutation in the cationic trypsinogen gene and chronic pancreatitis. Gastroenterology. 1999;117:1508–1509
  40. Chandak GR, Idris MM, Reddy DN, et al. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut. 2004;53:723–728
  41. Idris MM, Bhaskar S, Reddy DN, et al. Mutations in anionic trypsinogen gene are not associated with tropical calcific pancreatitis. Gut. 2005;54:728–729
  42. Mahurkar S, Idris MM, Reddy DN, et al. Association of cathepsin B gene polymorphism with tropical calcific pancreatitis. Gut. 2006;55:1270–1275
  43. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991;66:219–232
  44. Chance PF, Alderson MK, Leppig KA, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993;72:143–151
  45. Wolf NI, Sistermans EA, Cundall M, et al. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain. 2005;128(pt 4):743–751
  46. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science. 2003;302:841
  47. Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet. 2004;364:1167–1169
  48. Ibanez P, Bonnet AM, Debarges B, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson’s disease. Lancet. 2004;364:1169–1171
  49. Audrézet MP, Chen JM, Raguénès O, et al. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat. 2004;23:343–357
  50. Férec C, Casals T, Chuzhanova N, et al. Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms. Eur J Hum Genet. 2006;14:567–576

 Supported by the Programme Hospitalier de Recherche Clinique (grant PHRC R 08-04, C.F.), the INSERM, the Partenariats Institutions Citoyens pour la Recherche et l’Innovation (PICRI) project, the GIS Institut des Maladies Rares (project no. A07092NS), and the Association des Pancréatites Chroniques Héréditaires (APCH), France; and by the Council for Scientific and Industrial Research (CSIR), Government of India, India.

PII: S1542-3565(07)00965-2

doi: 10.1016/j.cgh.2007.10.004

Clinical Gastroenterology and Hepatology
Volume 6, Issue 1 , Pages 82-88 , January 2008